184 related articles for article (PubMed ID: 33160170)
41. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
42. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
[TBL] [Abstract][Full Text] [Related]
43. Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases.
Takei H; Suemasu K; Kurosumi M; Uchida K; Igarashi K; Ninomiya J; Naganuma R; Kusawake T; Sugamata N; Matsumoto H; Higashi Y
Breast Cancer; 2002; 9(4):344-8. PubMed ID: 12459717
[TBL] [Abstract][Full Text] [Related]
44. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
[TBL] [Abstract][Full Text] [Related]
45. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients.
Heuts EM; van der Ent FW; Hulsewé KW; Heeren PA; Hoofwijk AG
Acta Chir Belg; 2008; 108(2):203-7. PubMed ID: 18557144
[TBL] [Abstract][Full Text] [Related]
46. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
[TBL] [Abstract][Full Text] [Related]
47. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
48. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
49. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.
Okamoto T; Yamazaki K; Kanbe M; Kodama H; Omi Y; Kawamata A; Suzuki R; Igari Y; Tanaka R; Iihara M; Ito Y; Sawada T; Nishikawa T; Maki M; Kusakabe K; Mitsuhashi N; Obara T
Breast Cancer; 2005; 12(3):203-10. PubMed ID: 16110290
[TBL] [Abstract][Full Text] [Related]
50. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
51. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
52. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
53. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
54. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial.
Canavese G; Catturich A; Vecchio C; Tomei D; Gipponi M; Villa G; Carli F; Bruzzi P; Dozin B
Ann Oncol; 2009 Jun; 20(6):1001-7. PubMed ID: 19174453
[TBL] [Abstract][Full Text] [Related]
55. Axillary recurrence after negative sentinel lymph node biopsy.
Kim HJ; Son BH; Park EW; Lim WS; Seo JY; Jang MA; Ku BK; Ahn SH
Breast Cancer Res Treat; 2009 Mar; 114(2):301-5. PubMed ID: 18389366
[TBL] [Abstract][Full Text] [Related]
56. Primary cutaneous apocrine carcinoma: Case report and literature review.
Chadha S; Kumar R; Singhal S; Ruhela S
Indian J Pathol Microbiol; 2021; 64(1):183-185. PubMed ID: 33433438
[TBL] [Abstract][Full Text] [Related]
57. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
58. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
59. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
60. Case report: A rare case of eccrine carcinoma.
Kshirsagar AY; Wader JV; Nagur B; Biradar S; Savsaviya J; Chotai T; Agarwal A
Int J Surg Case Rep; 2015; 15():149-51. PubMed ID: 26367319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
